Helperby Management and Board

Our team combines world class science with industry experience

Helperby Therapeutics have a management team combining the required scientific, product/clinical development and product supply experience to gain both US and EU product approvals, and the commercial experience to develop the business from this early stage of the company growing to a company capable of launching and supplying products to patients.

Achieving this in a fully virtual organization, operating with the optimal partners, globally, is also a key part of Helperby management team experience.

  • James Phipson

    Interim Chairman and CEO

    An expert in the corporate governance of SMEs with over 30 years’ experience advising and managing high growth entrepreneurial businesses at board level, often internationally. Founder of professional services firm Dragon Argent, which provides legal, financial and HR services to over 400 SMEs at all stages from incorporation to listing.

  • Prof Anthony Coates

    Founder & Chief Scientific Officer

    Founder and CSO of Company. Author of 150 publications and 13 books; received numerous national and international grants from EU, UK MRC, charities and industry, and named inventor on many patents. Professor of Medical Microbiology at St. George’s University of London.

  • Dr Michael Dey

    Chief Operating Officer

    Over 30 NDA/MAAs approved; Last 12 years in R&D-commercialisation consultancy, developing and supply of 5 drugs to start-up clients, Commercial experience in growing €100M to >€1,000M business; Held multiple manufacturing, technology and product development leadership roles in small-large companies.

  • Dennis Molnar

    Non-Executive Director

    Over 20 years experience in pharma in various roles including CEO, finance, regulatory, operations, alliance management and licensing.

    Negotiated 10 out-licensing deals valued at $800M.

  • Patrick Mocatta

    Non-Executive Director

    Experience in International finance and private equity in Europe and the US, including Hambros Bank, First Chicago and UBS. Founding partner of Polaris Capital, a private equity firm in the US. Chairman of Gasrec Ltd, the leading supplier of road gas to heavy goods vehicle fleets in the UK.